Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis

Rheumatology (United Kingdom)

Volumn 52, Issue 2, 2013, Pages 261-266

  Jadon, Deepak ^a   Tillett, William ^b   Wallis, Dinny ^a   Cavill, Charlotte ^b   Bowes, John ^c   Waldron, Nicola ^a   Dixon, Anna ^b   Sengupta, Raj ^a   Barton, Anne ^c   Korendowych, Eleanor ^a   Mchugh, Neil J ^a,b  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b Bath Institute for Rheumatic Diseases   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Ankylosing spondylitis; ERAP1; HLA B27; IL12B; IL23R; Psoriatic arthritis; Radiographic axial disease; Radiographic sacroiliitis

Indexed keywords

AMINOPEPTIDASE; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; HLA B27 ANTIGEN; HLA C ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 23 RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; BONE EROSION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEALTH ASSESSMENT QUESTIONNAIRE; HOMOZYGOSITY; HUMAN; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NAIL SCORE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSORIASIS AREA SEVERITY INDEX; PSORIATIC ARTHRITIS; RATING SCALE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AMINOPEPTIDASES; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; INTERLEUKIN-12 SUBUNIT P40; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 84873838155     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes254     Document Type: Article

References (19)

1. Queiro R, Sarasqueta C, Belzunegui J, Gonzalez C, Figueroa M, Torre-Alonso JC. Psoriatic spondyloarthropathy: a comparative study between HLA-B27 positive and HLA-B27 negative disease. Semin Arthritis Rheum 2002;31:413-8.
2. Ho PY, Barton A, Worthington J et al. Investigating the role of the HLA-Cw*06 and HLA- DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis 2008; 67:677-82.
3. Filer C, Ho P, Smith RL et al. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum 2008;58:3705-9.
4. Rahman P, Inman RD, Maksymowych WP, Reeve JP, Peddle L, Gladman D. Association of interleukin 23 receptor variants with psoriatic arthritis. J Rheumatol 2009; 36:137-40.
5. Bowes J, Flynn E, Ho P et al. Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis. Ann Rheum Dis 2010;69:2199-203.
6. Huffmeier U, Uebe S, Ekici AB et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 2010;42: 996-9.
7. Rueda B, Orozco G, Raya E et al. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 2008; 67:1451-4.
8. Caffrey MF, James DC. Human lymphocyte antigen association with ankylosing spondylitis. Nature 1973;242: 121.
9. Evans DM, Spencer CC, Pointon JJ et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011;43: 761-7.
10. Burton PR, Clayton DG, Cardon LR et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39: 1329-37.
11. Strange A, Capon F, Spencer CC et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010;42:985-90.
12. Chandran V, Barrett J, Schentag CT, Farewell VT, Gladman DD. Axial psoriatic arthritis: update on a longterm prospective study. J Rheumatol 2009;36:2744-50.
13. Quanto Package. Version 1.2.3. http://hydra.usc.edu/gxe/ (28 August 2012, date last accessed).
14. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
15. Murphy CA, Langrish CL, Chen Y et al. Divergent proand anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003;198: 1951-57.
16. Gottlieb A, Menter A, Mendelsohn A. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet 2009;373: 633-40.
17. Al-Heresh AM, Proctor J, Jones SM et al. Tumour necrosis factor alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Rheumatology 2002;41:525-30.
18. Tsui FWL, Haroon N, Reveille JD et al. Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis 2010;69:733-6.
19. Goto Y, Hattori A, Ishii Y, Tsujimoto M. Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1. FEBS Lett 2006;580: 1833-8.